Resultado de búsqueda
Tras la administración de las dos dosis, seguidas de una dosis de refuerzo, la vacuna de Moderna tiene una eficacia real muy alta contra los síntomas graves, la hospitalización y la muerte, y moderada contra la infección sintomática. ¿Qué posología se recomienda?
The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
1 de nov. de 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
21 de ene. de 2021 · CORONAVIRUS. Al igual que la vacuna de Pfizer-BioNTech, la de Moderna se basa en las instrucciones genéticas del virus para ensamblar la proteína de espiga. ARNm dentro de una envoltura...
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated...
SPIKEVAX (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by ModernaTX, Inc. It is approved as a two-dose series for prevention of COVID-19 in individuals 18 years of...
